TREM2 suppresses the inflammatory response in vitro by repression of microglia-mediated cytokine production and secretion [21], and the anti-inflammatory effect of TREM2 was shown in an animal model of multiple sclerosis [22]. Here, TREM2 is linked to multiple sclerosis.